Moderna
MRNA
#1188
Rank
โ‚ฌ14.51 B
Marketcap
37,72ย โ‚ฌ
Share price
-0.43%
Change (1 day)
-56.18%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -โ‚ฌ2.17 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚ฌ5.05 Billion. In 2023 the company made an earning of -โ‚ฌ3.74 Billion a decrease over its 2022 earnings that were of โ‚ฌ9.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ2.17 Billion-42.01%
2023 -โ‚ฌ3.74 Billion-140.65%
2022 โ‚ฌ9.19 B-27.81%
2021 โ‚ฌ12.73 B-1911.15%
2020 -โ‚ฌ0.71 Billion44.7%
2019 -โ‚ฌ0.49 Billion28.63%
2018 -โ‚ฌ0.38 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ39.62 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.33 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ40 Million-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.18 Billion-91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.19 B-646.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-โ‚ฌ0.56 Billion-75.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.61 B-889.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.12 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA